Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/02/017763
CTRI/2019/02/017763
Completed
未知

A randomized double- blind cross-over study to assess the effect of regular and decaffeinated coffee on psychomotor performance in healthy volunteers during post-lunch period

Dr Suganthi S0 sites16 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Suganthi S
Enrollment
16
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 30, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Suganthi S

Eligibility Criteria

Inclusion Criteria

  • •1\.Age 21\-35 years
  • •2\.Willing to provide informed consent

Exclusion Criteria

  • •1\.Current Smokers (Adult who have smoked at least 100 cigarettes in their lifetime and who currently smokes cigarettes)
  • •2\.H/o medication intake (especially, H/o drugs causing psychomotor impairment (anti\-histamines, benzodiazepines), caffeine containing medicinal preparations, CYP1A2 inducers \& inhibitors))
  • •3\.H/o cough and cold for past 1 week
  • •4\.H/o caffeine use disorder (DSM V criteria)
  • •5\.H/o any other concurrent illness (hypertension, diabetes mellitus)
  • •6\.H/o heavy coffee drinking (consuming more than 4 cups of any type of coffee, caffeinated beverages every day)
  • •7\.H/o person who have never consumed caffeinated beverages or caffeine in any form
  • •8\.Pregnant and lactating females

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathy
EUCTR2010-023962-39-SEConvergence Pharmaceuticals Ltd85
Active, not recruiting
Not Applicable
A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathyeuropathic pain from lumbosacral radiculopathyMedDRA version: 14.1Level: PTClassification code 10050219Term: Lumbar radiculopathySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2010-023962-39-CZConvergence Pharmaceuticals Ltd85
Active, not recruiting
Not Applicable
A randomized, double blind, cross-over study to evaluate the safety and efficacy of CNV1014802 in subjects with neuropathic pain from lumbosacral radiculopathyeuropathic pain from lumbosacral radiculopathyMedDRA version: 14.1Level: PTClassification code 10050219Term: Lumbar radiculopathySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2010-023962-39-DKConvergence Pharmaceuticals Ltd85
Completed
Not Applicable
A study to see the effect of supplement with protein powder for better absorption of amino acids
CTRI/2024/01/061065Sanzyme Biologics P Ltd30
Active, not recruiting
Not Applicable
A randomised, double blind, crossover study to determine the mechanism of action of Gaviscon Advance in Gastro-Oesophageal Reflux Disease (GORD) - Gaviscon AdvanceGastro-oesophageal reflux disease (GORD)
EUCTR2010-019072-68-GBGuy's & St Thomas' NHS Foundation Trust